Performant Financial Corp... (PFMT)
NASDAQ: PFMT
· Real-Time Price · USD
3.56
-0.12 (-3.26%)
At close: Dec 17, 2024, 10:00 PM
Performant Financial Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Claims-Based Revenue | 19.71M | 17.1M | 62.2M | 14.22M | 25.8M | 31.13M | 28.49M | 23.93M | 22.89M | 26.03M | 23.52M | 21.76M | 23.36M | 25.56M | 20.01M | 18.6M | 13.29M | 18.87M | 17.57M | 14.59M | 17.52M | 14.29M | 10.76M | 9.26M | 10.17M | 7.47M | 6.09M | 31.31M |
| Claims-Based Revenue Growth | +15.24% | -72.50% | +337.53% | -44.90% | -17.13% | +9.28% | +19.06% | +4.53% | -12.05% | +10.66% | +8.10% | -6.88% | -8.59% | +27.75% | +7.55% | +40.01% | -29.58% | +7.40% | +20.37% | -16.73% | +22.65% | +32.83% | +16.13% | -8.95% | +36.09% | +22.64% | -80.54% | n/a |
| Eligibility-Based Revenue | 18.09M | 16.08M | n/a | 16.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Eligibility-Based Revenue Growth | +12.50% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Health Care Revenue | 37.8M | 33.19M | n/a | 30.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Health Care Revenue Growth | +13.91% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | 73.72M | 25.97M | 24.53M | 23.22M | 23.31M | 22.98M | 21.71M | 22.45M | 22.21M | 21.76M | 20.9M | 20.44M | 20.37M | 19.69M | 23.3M | 24.09M | 26.16M | 23.52M | 22.17M | 28.8M | 28.38M | 28.77M | 28.93M | 29.12M | 27.78M | 24.28M | 22.3M | 21.78M | 20.55M | 20.49M | 20.45M | 20.7M | 18.76M | 18.71M | 20.06M | 21.34M | 20.48M | 21.73M | 22.14M | 23.72M |
| Selling, General, and Administrative Revenue Growth | n/a | -100.00% | +183.91% | +5.84% | +5.65% | -0.37% | +1.43% | +5.85% | -3.29% | +1.07% | +2.08% | +4.10% | +2.27% | +0.34% | +3.47% | -15.49% | -3.30% | -7.92% | +11.22% | +6.12% | -23.05% | +1.50% | -1.37% | -0.55% | -0.64% | +4.80% | +14.44% | +8.84% | +2.41% | +5.99% | +0.28% | +0.22% | -1.19% | +10.34% | +0.25% | -6.73% | -5.98% | +4.17% | -5.74% | -1.87% | -6.67% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 4.3M | n/a | n/a | n/a | 3.4M | n/a | n/a | n/a | 3M | n/a | n/a | n/a | 3.1M | n/a | n/a | n/a | 5.8M | n/a | n/a | n/a | 6.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |